Medscape Oncology

Dr Bruce Cheson previews the most important trials being presented at ASCO 2015 on Hodgkin's and non-Hodgkin's lymphoma, acute and chronic leukemia, and multiple myeloma.

Dr John Marshall puts his vacation on hold to highlight the themes of ASCO 2015, including the critical question: What is value in cancer care, and how much is riding on the correct answer?

When it comes to progression in a patient with EGFR-mutant lung cancer, it's by no means one-size-fits-all. Dr Mark Kris discusses treatment options.

Squamous cell tumors represent 20% of all lung cancers. Dr Mark Kris discusses new approaches to the diagnosis and treatment of these tumors, including nivolumab and ramucirumab.

In a moving story, Dr Eunice Lee reveals how a prenatal genetic test led to a cancer diagnosis and saved her life.

Gerald Chodak comments on a new study that suggests that a baseline low PSA level can save many men the agony of frequent follow-up.

Dr Mark Kris discusses the details of the IMPRESS trial, which assessed the effect of discontinuing gefitinib in patients with EGFR-mutant lung cancer who have developed resistance to the drug.

Jimmie Holland, MD, a pioneer of psycho-oncology who was featured in the PBS documentary 'Cancer,' discusses the importance of treating the patient as well as the cancer--and how little time it takes.

Eric Topol speaks with singer, songwriter, and oncologic scientist Nazneen Rahman on the importance of understanding the genetics of cancer.

A new study finds that men who are newly diagnosed with prostate cancer have a higher risk for suicide within the first year, raising the stakes for clinicians to provide appropriate care.